Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

North America Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Treatment Type , By End User (Dermatological Clinics, Hospitals, and Others), By Disorder Type (Melasma, Age Spot, and Others). By Country and Growth Forecast, 2023 - 2030

Published Date : 08-Apr-2024

Pages: 111

Formats: PDF

The North America Hyperpigmentation Treatment Market would witness market growth of 7.4% CAGR during the forecast period (2023-2030).

The US market dominated the North America Hyperpigmentation Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,287.3 million by 2030. The Canada market is experiencing a CAGR of 9.8% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 8.9% during (2023 - 2030).

North America Hyperpigmentation Treatment Market

The trend toward personalized skincare regimens has permeated the hyperpigmentation treatment market. Consumers increasingly seek treatments tailored to their skin types, concerns, and lifestyles. The availability of personalized treatment plans, incorporating a mix of topical formulations, laser therapies, and other interventions, enhances the overall efficacy of hyperpigmentation treatments and fosters a sense of individualized care. The psychological and aesthetic impact of hyperpigmentation on an individual’s confidence and self-esteem is a significant driver for adoption. As societal attitudes shift towards recognizing the importance of mental well-being and self-confidence, more people are actively seeking solutions to address pigmentation concerns, viewing these treatments as improving their skin’s appearance and overall quality of life.

It is associated with hormonal fluctuations, pregnancy, and the sun exposure, melasma is a prevalent skin condition characterized by dark patches, which frequently appear on the face. Hyperpigmentation treatments are frequently employed to lighten these dark patches and improve overall skin tone. PIH occurs because of skin inflammation, such as acne or other injuries. Hyperpigmentation treatments help reduce the discoloration left behind after the inflammatory process, promoting a more even skin tone. Sunspots, age spots, or hyperpigmentation areas can form due to prolonged sun exposure.

According to the Canadian Institute for Health Information, Canada’s senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Hence, the factors mentioned above will drive the regional market growth.

Free Valuable Insights: The Hyperpigmentation Treatment Market is Predict to reach USD 9.3 Billion by 2030, at a CAGR of 8.2%

Based on Treatment Type, the market is segmented into Topical Agent, Photo Therapy, and Microdermabrasion. Based on End User, the market is segmented into Dermatological Clinics, Hospitals, and Others. Based on Disorder Type, the market is segmented into Melasma, Age Spot, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Vivier Pharma Inc.
  • Pierre Fabre S.A
  • Aerolase
  • L'Oréal S.A.
  • CP Skin Health Group, Inc. (The Colgate Palmolive Company)
  • Trophy Skin Products LLC
  • The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
  • Episciences, Inc.
  • The Procter and Gamble Company
  • Galderma S.A.

North America Hyperpigmentation Treatment Market Report Segmentation

By Treatment Type

  • Topical Agent
  • Photo Therapy
  • Microdermabrasion

By End User

  • Dermatological Clinics
  • Hospitals
  • Others

By Disorder Type

  • Melasma
  • Age Spot
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hyperpigmentation Treatment Market, by Treatment Type
1.4.2 North America Hyperpigmentation Treatment Market, by End User
1.4.3 North America Hyperpigmentation Treatment Market, by Disorder Type
1.4.4 North America Hyperpigmentation Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. North America Hyperpigmentation Treatment Market by Treatment Type
4.1 North America Topical Agent Market by Country
4.2 North America Photo Therapy Market by Country
4.3 North America Microdermabrasion Market by Country

Chapter 5. North America Hyperpigmentation Treatment Market by End User
5.1 North America Dermatological Clinics Market by Country
5.2 North America Hospitals Market by Country
5.3 North America Others Market by Country

Chapter 6. North America Hyperpigmentation Treatment Market by Disorder Type
6.1 North America Melasma Market by Country
6.2 North America Age Spot Market by Country
6.3 North America Others Market by Country

Chapter 7. North America Hyperpigmentation Treatment Market by Country
7.1 US Hyperpigmentation Treatment Market
7.1.1 US Hyperpigmentation Treatment Market by Treatment Type
7.1.2 US Hyperpigmentation Treatment Market by End User
7.1.3 US Hyperpigmentation Treatment Market by Disorder Type
7.2 Canada Hyperpigmentation Treatment Market
7.2.1 Canada Hyperpigmentation Treatment Market by Treatment Type
7.2.2 Canada Hyperpigmentation Treatment Market by End User
7.2.3 Canada Hyperpigmentation Treatment Market by Disorder Type
7.3 Mexico Hyperpigmentation Treatment Market
7.3.1 Mexico Hyperpigmentation Treatment Market by Treatment Type
7.3.2 Mexico Hyperpigmentation Treatment Market by End User
7.3.3 Mexico Hyperpigmentation Treatment Market by Disorder Type
7.4 Rest of North America Hyperpigmentation Treatment Market
7.4.1 Rest of North America Hyperpigmentation Treatment Market by Treatment Type
7.4.2 Rest of North America Hyperpigmentation Treatment Market by End User
7.4.3 Rest of North America Hyperpigmentation Treatment Market by Disorder Type

Chapter 8. Company Profiles
8.1 Vivier Pharma Inc.
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Pierre Fabre S.A
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.3 SWOT Analysis
8.3 Aerolase
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 L'Oréal S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.5 SWOT Analysis
8.5 The Procter & Gamble Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Galderma S.A.
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 CP Skin Health Group, Inc. (The Colgate Palmolive Company)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Trophy Skin Products LLC
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. Episciences, Inc.
8.10.1 Company Overview
8.10.2 SWOT Analysis
TABLE 1 North America Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
TABLE 2 North America Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
TABLE 3 North America Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
TABLE 4 North America Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
TABLE 5 North America Topical Agent Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Topical Agent Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Photo Therapy Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Photo Therapy Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Microdermabrasion Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Microdermabrasion Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
TABLE 12 North America Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
TABLE 13 North America Dermatological Clinics Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Dermatological Clinics Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
TABLE 20 North America Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
TABLE 21 North America Melasma Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Melasma Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Age Spot Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Age Spot Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Hyperpigmentation Treatment Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Hyperpigmentation Treatment Market by Country, 2023 - 2030, USD Million
TABLE 29 US Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
TABLE 30 US Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
TABLE 31 US Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
TABLE 32 US Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
TABLE 33 US Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
TABLE 34 US Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
TABLE 35 US Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
TABLE 36 US Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
TABLE 37 Canada Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
TABLE 38 Canada Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
TABLE 39 Canada Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
TABLE 40 Canada Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
TABLE 41 Canada Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
TABLE 42 Canada Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
TABLE 43 Canada Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
TABLE 44 Canada Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
TABLE 45 Mexico Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
TABLE 46 Mexico Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
TABLE 47 Mexico Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
TABLE 48 Mexico Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
TABLE 49 Mexico Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
TABLE 50 Mexico Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
TABLE 51 Mexico Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
TABLE 52 Mexico Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
TABLE 53 Rest of North America Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
TABLE 54 Rest of North America Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
TABLE 55 Rest of North America Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
TABLE 56 Rest of North America Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
TABLE 57 Rest of North America Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
TABLE 58 Rest of North America Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
TABLE 59 Rest of North America Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
TABLE 60 Rest of North America Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
TABLE 61 Key Information – Vivier Pharma Inc.
TABLE 62 Key Information – Pierre Fabre S.A
TABLE 63 Key Information – aerolase
TABLE 64 Key Information – L'Oréal S.A.
TABLE 65 Key Information – The Procter & Gamble Company
TABLE 66 Key Information – Galderma S.A.
TABLE 67 Key Information – CP Skin Health Group, inc.
TABLE 68 Key Information – Trophy Skin Products LLC
TABLE 69 Key Information – The Alchemee LLC
TABLE 70 Key Information – Episciences, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Hyperpigmentation Treatment Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Hyperpigmentation Treatment Market
FIG 4 Porter’s Five Forces Analysis - Hyperpigmentation Treatment Market
FIG 5 North America Hyperpigmentation Treatment Market share by Treatment Type, 2022
FIG 6 North America Hyperpigmentation Treatment Market share by Treatment Type, 2030
FIG 7 North America Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2030, USD Million
FIG 8 North America Hyperpigmentation Treatment Market share by End User, 2022
FIG 9 North America Hyperpigmentation Treatment Market share by End User, 2030
FIG 10 North America Hyperpigmentation Treatment Market by End User, 2019 - 2030, USD Million
FIG 11 North America Hyperpigmentation Treatment Market share by Disorder Type, 2022
FIG 12 North America Hyperpigmentation Treatment Market share by Disorder Type, 2030
FIG 13 North America Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2030, USD Million
FIG 14 North America Hyperpigmentation Treatment Market share by Country, 2022
FIG 15 North America Hyperpigmentation Treatment Market share by Country, 2030
FIG 16 North America Hyperpigmentation Treatment Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Vivier Pharma Inc.
FIG 18 SWOT Analysis: Pierre Fabre S.A
FIG 19 SWOT Analysis: Aerolase
FIG 20 Swot Analysis: L'Oréal S.A.
FIG 21 SWOT Analysis: The Procter & Gamble Company
FIG 22 SWOT Analysis: Galderma S.A.
FIG 23 SWOT Analysis: CP Skin Health Group, Inc.
FIG 24 SWOT Analysis: Trophy Skin Products LLC
FIG 25 SWOT Analysis: The Alchemee LLC
FIG 26 SWOT Analysis: Episciences, Inc.

Purchase Full Report of
North America Hyperpigmentation Treatment Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL